Non-adherence to polypharmacy in older adults Not Applicable
Conditions
Interventions
The intervention will be delivered to non-adherent older adults by a trained community pharmacist over three (30-40 minute) appointments held within the community pharmacy. At Appointment 1, the pharm
Sponsors
Queen's University Belfast
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Community pharmacist participants: 1. Located in Northern Ireland 2. At least one pharmacist (maximum 2) willing to take part in the study and provide written informed consent 3. Access to a private consultation room/area 4. Access to printing facilities Patient participants: 1. Aged 65 years or older 2. Prescribed four or more regular medications (excluding medications prescribed to be taken only when required or medicines purchased over-the-counter) 3. Living in their own home 4. Have at least six months of dispensing data available from the time of screening (on the pharmacy-held Patient Medication Record) 5. Only attend the study site pharmacy for regular medications 6. Have an identified adherence problem (detected using self-report adherence questionnaire)
Exclusion criteria
Exclusion criteria: Community pharmacist participants: 1. Not meeting the inclusion criteria 2. Not proving written informed consent Patient participants: 1. Not meeting the inclusion criteria 2. Not providing written informed consent 3. Prescribed medications for the treatment or management of dementia (e.g. donepezil, galantamine, rivastigmine or memantine) 4. Unable to complete the Eligibility Screening Questionnaire 5. Has high adherence (as detected using self-report adherence questionnaire)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Usability and acceptability of the intervention from the viewpoint of community pharmacists using qualitative face-to-face interviews conducted following the completion of all patient appointments 2. Usability and acceptability of the intervention from the viewpoint of older patients using qualitative telephone interviews conducted after the patient has attended their final intervention appointment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Feasibility of the screening strategy (i.e. inclusion and exclusion criteria), recruitment strategy and willingness of participants to be recruited, assessed based on the numbers approached and those who are subsequently recruited 2. Feasibility of data collection procedures, assessed by collecting data on self-reported adherence and health-related quality of life via validated questionnaires, and collecting data from pharmacy-held Patient Medication Records to calculate objective measures of medication adherence such as Medication Possession Ratios 3. Fidelity to the intervention, assessed by examining materials (e.g. appointment check lists, summary notes) completed by pharmacists during the study. Pharmacists and patients are also asked about the delivery and receipt of components of the intervention, during qualitative feedback interviews | — |
Countries
United Kingdom
Outcome results
None listed